QNCX

Quince Therapeutics (QNCX)

Quince Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:QNCX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/09	09:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2025/01/09	09:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2025/01/09	09:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2024/12/28	06:01	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:QNCX	Quince Therapeutics Inc
2024/12/27	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:QNCX	Quince Therapeutics Inc
2024/12/19	06:03	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:QNCX	Quince Therapeutics Inc
2024/11/14	20:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2024/11/14	11:17	Edgar (US Regulatory)	Form SC 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:QNCX	Quince Therapeutics Inc
2024/11/14	07:09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QNCX	Quince Therapeutics Inc
2024/11/14	06:05	Business Wire	Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results	NASDAQ:QNCX	Quince Therapeutics Inc
2024/11/13	06:05	Business Wire	Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research	NASDAQ:QNCX	Quince Therapeutics Inc
2024/11/12	06:05	Business Wire	Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting	NASDAQ:QNCX	Quince Therapeutics Inc
2024/10/15	05:05	Business Wire	Quince Therapeutics to Participate at Upcoming Investor Conferences	NASDAQ:QNCX	Quince Therapeutics Inc
2024/09/04	05:05	Business Wire	Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:QNCX	Quince Therapeutics Inc
2024/08/22	07:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2024/08/15	20:00	Business Wire	Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)	NASDAQ:QNCX	Quince Therapeutics Inc
2024/08/14	05:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QNCX	Quince Therapeutics Inc
2024/08/14	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2024/08/14	05:05	Business Wire	Quince Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results	NASDAQ:QNCX	Quince Therapeutics Inc
2024/06/25	20:00	Business Wire	Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia	NASDAQ:QNCX	Quince Therapeutics Inc
2024/06/08	10:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2024/06/08	10:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2024/06/08	09:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2024/06/07	06:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2024/06/06	03:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2024/06/03	20:00	Business Wire	Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System	NASDAQ:QNCX	Quince Therapeutics Inc
2024/05/13	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QNCX	Quince Therapeutics Inc
2024/05/13	20:00	Business Wire	Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:QNCX	Quince Therapeutics Inc
2024/05/07	05:05	Business Wire	Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference	NASDAQ:QNCX	Quince Therapeutics Inc
2024/04/01	20:00	Business Wire	Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results	NASDAQ:QNCX	Quince Therapeutics Inc